NCT02024971View on ClinicalTrials.gov

Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

1,103

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Pioglitazone/metformin hydrochloride

Pioglitazone/metformin hydrochloride combination tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY